Bantikassegn Amlak
Atrium Health, Charlotte, North Carolina, USA.
J Hosp Palliat Care. 2024 Sep 1;27(3):99-102. doi: 10.14475/jhpc.2024.27.3.99.
The use of antimicrobials in patients receiving end-of-life (EOL) care, which is generally defined as supportive care provided to patients anticipated to live less than 1 year, has been actively debated in the realm of palliative care medicine due to the nebulous nature of the topic. In this article, we explore the use of antimicrobial use near EOL as it relates to both the ethical and practical issues that face physicians. We also discuss the reasons underlying the scarcity of prospective studies on this topic.
在接受临终关怀(EOL)的患者中使用抗菌药物,通常是指为预期存活时间少于1年的患者提供的支持性护理,由于该主题性质模糊,在姑息治疗医学领域一直存在积极的争论。在本文中,我们探讨临终时抗菌药物的使用情况,因为它涉及到医生面临的伦理和实际问题。我们还讨论了关于该主题的前瞻性研究稀缺的潜在原因。